One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

NCT00117286 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer

NCT01491971 ·Status: COMPLETED ·Phase: PHASE2

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

NCT00116779 ·Status: COMPLETED ·Phase: PHASE2

A Degarelix Trial in Patients With Prostate Cancer

NCT01242748 ·Status: TERMINATED ·Phase: PHASE3

Open-Label, Randomised Parallel-Group Study

NCT00728533 ·Status: WITHDRAWN ·Phase: PHASE3

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

NCT00116753 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer

NCT00819247 ·Status: COMPLETED ·Phase: PHASE2

Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer

NCT00801242 ·Status: COMPLETED ·Phase: PHASE3

Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

NCT00245466 ·Status: TERMINATED ·Phase: PHASE2

An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer

NCT00215683 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

NCT01215513 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy

NCT00451958 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

NCT00295750 ·Status: COMPLETED ·Phase: PHASE3

Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Cancer

NCT01542021 ·Status: COMPLETED ·Phase: NA

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

NCT00884273 ·Status: COMPLETED ·Phase: PHASE3

Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients

NCT00117312 ·Status: TERMINATED ·Phase: PHASE2

Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)

NCT01630967 ·Status: UNKNOWN ·Phase: PHASE2

Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer

NCT00738673 ·Status: COMPLETED ·Phase: PHASE2

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists

NCT01366053 ·Status: COMPLETED

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

NCT00833248 ·Status: COMPLETED ·Phase: PHASE3

Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer

NCT00819156 ·Status: COMPLETED ·Phase: PHASE2

Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy

NCT00468286 ·Status: COMPLETED ·Phase: PHASE2

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

NCT00831233 ·Status: TERMINATED ·Phase: PHASE3

Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy

NCT01446991 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

NCT02726009 ·Status: COMPLETED ·Phase: PHASE4